Get the Facts

Find what you need to know
in our brochures.


Get our
Press Kit

Official information for
articles and stories.


Multiple Myeloma News

Sort by Category:

Real Precision Medicine Requires Real Access to Patient Data

In an increasingly digital age, immediacy has become the name of the game. A simple Google search gives us answers instantaneously and the cloud allows us to store and recover information at the drop of a hat. We take these for granted, but scientists and medical professionals do not have these luxuries when they are trying to access patient data to search for important treatments and cures. Read More

September 30, 2015

Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma.

Meads MB, Fang B, Mathews L, Gemmer J, Nong L, Rosado-Lopez I, Nguyen T, Ring JE, Matsui W, MacLeod AR, Pachter JA, Hazlehurst LA, Koomen JM, Shain KH. Oncogene. 2015 Sep 21. doi: 10.1038/onc.2015.334. [Epub ahead of print] PMID: 26387544 [PubMed - as supplied by publisher] Read More

September 24, 2015

Carfilzomib, pomalidomide, and dexamethasone (CPD) in patients with relapsed and/or refractory multiple myeloma.

Shah JJ, Stadtmauer EA, Abonour R, Cohen AD, Bensinger WI, Gasparetto C, Kaufman JL, Lentzsch S, Vogl DT, Gomes CL, Pascucci N, Smith DD, Orlowski RZ, Durie BG. Blood. 2015 Sep 17. pii: blood-2015-05-643320. [Epub ahead of print] PMID: 26384354 [PubMed - as supplied by publisher] Read More

September 24, 2015

Page 1 of 6012345...102030...Last »